← Open Payments lookup

ANNA GORELIK: Open Payments

NPI 1407139801 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,076 in 96 payments from 25 companies in 2025. Trend: 2023 $2,942 · 2024 $2,486 · 2025 $4,076

Food & beverage: $2,357Consulting: $1,344Education: $375
CompanyPaymentsAmount
Regeneron Pharmaceuticals, Inc.2$1,344
GENZYME CORPORATION8$369
AstraZeneca Pharmaceuticals LP10$335
HARMONY BIOSCIENCES LLC9$282
Viatris Specialty LLC13$221
Verona Pharma, Inc.8$217
Regeneron Healthcare Solutions, Inc.4$208
GlaxoSmithKline, LLC.7$162
Actelion Pharmaceuticals US, Inc.2$123
Insmed, Inc.5$112

Products named: DUPIXENT, YUPELRI, WAKIX, Ohtuvayre, TEZSPIRE, TRELEGY ELLIPTA, OPSUMIT, Prolastin-C Liquid.

Industry payments across NY — which companies pay providers there.